These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 17964975

  • 21. Severe malaria in Cameroonian children: correlation between plasma levels of three soluble inducible adhesion molecules and TNF-alpha.
    Tchinda VH, Tadem AD, Tako EA, Tene G, Fogako J, Nyonglema P, Sama G, Zhou A, Leke RG.
    Acta Trop; 2007 Apr; 102(1):20-8. PubMed ID: 17397790
    [Abstract] [Full Text] [Related]

  • 22. Tumour necrosis factor alpha in uncomplicated malaria in young adults.
    Puta C, Hansen MB.
    Trop Geogr Med; 1995 Apr; 47(3):134-5. PubMed ID: 7483005
    [Abstract] [Full Text] [Related]

  • 23. Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.
    Grobusch MP, Lell B, Schwarz NG, Gabor J, Dornemann J, Potschke M, Oyakhirome S, Kiessling GC, Necek M, Langin MU, Klein Klouwenberg P, Klopfer A, Naumann B, Altun H, Agnandji ST, Goesch J, Decker M, Salazar CL, Supan C, Kombila DU, Borchert L, Koster KB, Pongratz P, Adegnika AA, Glasenapp Iv, Issifou S, Kremsner PG.
    J Infect Dis; 2007 Dec 01; 196(11):1595-602. PubMed ID: 18008242
    [Abstract] [Full Text] [Related]

  • 24. Tumor necrosis factor in Plasmodium falciparum malaria: high plasma level is associated with fever, but high production capacity is associated with rapid fever clearance.
    Mordmüller BG, Metzger WG, Juillard P, Brinkman BM, Verweij CL, Grau GE, Kremsner PG.
    Eur Cytokine Netw; 1997 Mar 01; 8(1):29-35. PubMed ID: 9110145
    [Abstract] [Full Text] [Related]

  • 25. Implications of dynamic changes among tumor necrosis factor-alpha (TNF-alpha), membrane TNF receptor, and soluble TNF receptor levels in regard to the severity of dengue infection.
    Wang L, Chen RF, Liu JW, Yu HR, Kuo HC, Yang KD.
    Am J Trop Med Hyg; 2007 Aug 01; 77(2):297-302. PubMed ID: 17690402
    [Abstract] [Full Text] [Related]

  • 26. Immune responses after single-dose sulphadoxine-pyrimethamine indicate underestimation of protective efficacy of intermittent preventive treatment in infants.
    Schreiber N, Kobbe R, Adjei S, Adjei O, Klinkert MQ, May J.
    Trop Med Int Health; 2007 Oct 01; 12(10):1157-63. PubMed ID: 17956497
    [Abstract] [Full Text] [Related]

  • 27. Association between cigarette smoking and release of tumour necrosis factor alpha and its soluble receptors by peripheral blood mononuclear cells in patients with rheumatoid arthritis.
    Glossop JR, Dawes PT, Mattey DL.
    Rheumatology (Oxford); 2006 Oct 01; 45(10):1223-9. PubMed ID: 16585133
    [Abstract] [Full Text] [Related]

  • 28. Effectiveness of quinine monotherapy for the treatment of Plasmodium falciparum infection in pregnant women in Lambaréné, Gabon.
    Adegnika AA, Breitling LP, Agnandji ST, Chai SK, Schütte D, Oyakhirome S, Schwarz NG, Grobusch MP, Missinou MA, Ramharter M, Issifou S, Kremsner PG.
    Am J Trop Med Hyg; 2005 Aug 01; 73(2):263-6. PubMed ID: 16103585
    [Abstract] [Full Text] [Related]

  • 29. The effect of soluble tumor necrosis factor receptor-II on endotoxin-mediated hemodynamic instability.
    Anderson JA, Knott AW, Wilson MA, Garrison RN, Sims DE, Edwards MJ.
    J Surg Res; 1995 Jan 01; 58(1):53-7. PubMed ID: 7830406
    [Abstract] [Full Text] [Related]

  • 30. Tumor necrosis factor-alpha in patients with malaria.
    Singh S, Singh N, Handa R.
    Indian J Malariol; 2000 Jan 01; 37(1-2):27-33. PubMed ID: 11820079
    [Abstract] [Full Text] [Related]

  • 31. Influence of tumor necrosis factor-alpha on the ability of monocytes and lymphocytes to destroy intraerythrocytic Plasmodium falciparum in vitro.
    Muniz-Junqueira MI, dos Santos-Neto LL, Tosta CE.
    Cell Immunol; 2001 Mar 15; 208(2):73-9. PubMed ID: 11333139
    [Abstract] [Full Text] [Related]

  • 32. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.
    Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP, Madani H, Widmer MB.
    J Immunol; 1993 Aug 01; 151(3):1548-61. PubMed ID: 8393046
    [Abstract] [Full Text] [Related]

  • 33. Soluble TNFR II/IgG1 Fc fusion protein treatment in the LPS-mediated septic shock of rats.
    Guo Z, Wang S, Jiao Q, Xu M, Xu Z.
    Biomed Pharmacother; 2009 Aug 01; 63(7):537-42. PubMed ID: 18848768
    [Abstract] [Full Text] [Related]

  • 34. Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.
    Boggild AK, Krudsood S, Patel SN, Serghides L, Tangpukdee N, Katz K, Wilairatana P, Liles WC, Looareesuwan S, Kain KC.
    Clin Infect Dis; 2009 Sep 15; 49(6):841-9. PubMed ID: 19673614
    [Abstract] [Full Text] [Related]

  • 35. Ex vivo and in vitro impairment of CD36 expression and tumor necrosis factor-alpha production in human monocytes in response to Plasmodium falciparum-parasitized erythrocytes.
    Berry A, Chene G, Benoit-Vical F, Lepert JC, Bernad J, Marchou B, Séguéla JP, Magnaval JF, Pipy B.
    J Parasitol; 2005 Apr 15; 91(2):316-22. PubMed ID: 15986606
    [Abstract] [Full Text] [Related]

  • 36. Treatment with soluble tumor necrosis factor receptor (sTNFR):Fc/p80 fusion protein ameliorates relapsing-remitting experimental autoimmune encephalomyelitis and decreases chemokine expression.
    Glabinski AR, Bielecki B, Kawczak JA, Tuohy VK, Selmaj K, Ransohoff RM.
    Autoimmunity; 2004 Apr 15; 37(6-7):465-71. PubMed ID: 15621573
    [Abstract] [Full Text] [Related]

  • 37. Assessment of the therapeutic efficacy of chloroquine in the treatment of uncomplicated Plasmodium falciparum malaria in a tribal block of the Kalahandi district of Orissa, India.
    Kerketta AS, Mohapatra SS, Kar SK.
    Trop Doct; 2008 Apr 15; 38(2):82-4. PubMed ID: 18453492
    [Abstract] [Full Text] [Related]

  • 38. [Estimation and clinical significance of serum soluble tumor necrosis factor receptors in patients with acute leukemia].
    Lin M, Meng X.
    Zhonghua Xue Ye Xue Za Zhi; 1999 May 15; 20(5):245-8. PubMed ID: 11601213
    [Abstract] [Full Text] [Related]

  • 39. A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya.
    Othoro C, Lal AA, Nahlen B, Koech D, Orago AS, Udhayakumar V.
    J Infect Dis; 1999 Jan 15; 179(1):279-82. PubMed ID: 9841855
    [Abstract] [Full Text] [Related]

  • 40. Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria.
    Hemmer CJ, Holst FG, Kern P, Chiwakata CB, Dietrich M, Reisinger EC.
    Trop Med Int Health; 2006 Jun 15; 11(6):817-23. PubMed ID: 16772003
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.